Status:
COMPLETED
Study to Assess Duration of Indwelling Catheter After Sacrocolpopexy
Lead Sponsor:
Oregon Health and Science University
Conditions:
Pelvic Organ Prolapse
Urinary Tract Infections
Eligibility:
FEMALE
21-85 years
Phase:
NA
Brief Summary
Objectives The objective of this study is to help identify the best practice regarding the use of indwelling catheter after minimally invasive urogynecologic surgery. Investigators propose a randomiz...
Detailed Description
Objectives The objective of this study is to help identify the best practice regarding the use of indwelling catheter after minimally invasive urogynecologic surgery. Investigators propose a randomiz...
Eligibility Criteria
Inclusion
- Women undergoing minimally invasive sacrocolpopexy
- Sacrocolpopexy with or without concomitant procedures
- Patients having the first start surgery of the day to standardize hospital time.
Exclusion
- Elevated post void residual (PVR)
- Mobility problems
- Neurological conditions
- Intra-operative cystotomy or urinary tract injury
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT02189291
Start Date
July 1 2014
End Date
December 31 2018
Last Update
March 15 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
St John Hospital & Medical Center
Detroit, Michigan, United States, 48236
2
Oregon Health & Science University
Portland, Oregon, United States, 97239
3
Legacy Good Samaritan Medical Center
Portland, Oregon, United States